Results 111 to 120 of about 92,287 (149)

Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series. [PDF]

Front Immunol
Deng M, Chen L, Chen W, Zeng K, Yao Y, Chen H, Lin A.   +6 more
europepmc   +1 more source

Seronegative Neuromyelitis Optica Spectrum Disorder in a Six-Year-Old Patient: A Case Report. [PDF]

Cureus
Pinacho-Velázquez JL, Rueda-Velázquez JJ, Martínez-Juárez O, Perez Sanjulian-Krasovsky E, Pérez-Trueba FE.   +4 more
europepmc   +1 more source

Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China. [PDF]

Mult Scler J Exp Transl Clin
Huang X, Feng H, Li J, Fan Y, Zeng J.
europepmc   +1 more source

Distinct macular structural and microvascular alterations differentiate neuromyelitis optica spectrum disorder from myelin oligodendrocyte glycoprotein antibody-associated disease in optic neuritis. [PDF]

Front Immunol
Zhang M, Liu Z, Li Y, Li Y, Ma R, Lu Q, Liu P, Liu Y, Chang Q, Wang Y, Song C, Huo Y, Rao L, Cao S, Wang N, Li G, Wu F, Liu T, Peng L, Hao Y, Cao Z, Lin X, Zhou X, Wu S.   +23 more
europepmc   +1 more source

Advances in Digital Holography, 3-D Imaging, and Optical Information Processing: introduction. [PDF]

Biomed Opt Express
Nehmetallah G, Miccio L, Latychevskaia T, Nishchal NK, Luo Y.   +4 more
europepmc   +1 more source

Recurrent aquaporin 4-immunoglobulin G-positive neuromyelitis optica spectrum disorder in a patient with long-standing rheumatoid arthritis: A case report. [PDF]

J Int Med Res
Jiang X, Chen J, Wen Y, Yuan L, Zhang J.
europepmc   +1 more source

Efficacy and safety of efgartigimod as an add-on therapy in patients with NMOSD and MOGAD at the acute attack phase. [PDF]

Front Immunol
Yin W, Wang S, Lu W, Duan T.
europepmc   +1 more source

Efficacy of Ravulizumab During the Acute Phase of Neuromyelitis Optica Spectrum Disorder. [PDF]

Case Rep Neurol Med
Tsuzaki K, Mitsui G, Inagaki Y, Uehara N, Wada S, Hamano T.   +5 more
europepmc   +1 more source

Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report. [PDF]

Front Immunol
Ding M, Yin B, Yao J, Liu Y, Dong H, Lu Z.   +5 more
europepmc   +1 more source

Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists. [PDF]

Mult Scler J Exp Transl Clin
Saposnik G, Solanes A, Monreal E, Sepúlveda M, Hernández MÁ, Cuello JP, Álvarez-Bravo G, Agüera-Morales E, Riancho J, Pérez-Sempere Á, Maurino J, Gómez-Ballesteros R.   +11 more
europepmc   +1 more source